Furthermore, while tumor-bearing animals treated with control antibody did have elevated IFNγ levels compared with nontumor-bearing animals, the levels of IFNγ were 20-fold lower than levels observed in animals that had tumor regressions following combination treatment (Fig. 4b). Here, IFNG is linked to neoplasm.